Evidence map›Paper›PMID 36549941›Full record

ArticleVaccine2023

Changes in hepatitis B vaccine perception in response to the COVID-19 pandemic: Development of the Shift in vaccine confidence (SVC) survey tool.

Alix Boisson, Camille E Morgan, Angela Stover, Patrick Ngimbi, Nana Mbonze, Sarah Ntambua, Jolie Matondo, Jonathan B Parr, Marcel Yotebieng, Kashamuka Mwandagalirwa and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The next viral pandemic-where do we stand?Folia microbiologica · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alix BoissonDepartment of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, NC, 27599, USA. Electronic address: aboisson@unc.edu.
Camille E MorganDepartment of Epidemiology, Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, NC, 27599, USA. Electronic address: camille_morgan@med.unc.edu.
Angela StoverDepartment of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, NC, 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599. Electronic address: stoveram@email.unc.edu.
Patrick NgimbiUniversité Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: patrickngimbi1@gmail.com.
Nana MbonzeUniversité Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: mbonzenana@gmail.commbo.
Sarah NtambuaUniversité Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: sarahntambua2017@gmiail.com.
Jolie MatondoUniversité Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: joliematondo83@gmail.com.
Jonathan B ParrDivision of Infectious Diseases, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. Electronic address: jonathan_parr@med.unc.edu.
Marcel YotebiengDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, 10461, USA. Electronic address: marcel.yotebieng@einsteinmed.org.
Kashamuka MwandagalirwaUniversité Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: mkashamuka@yahoo.com.
Linda JamesUniversité Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: lindajames.la@gmail.com.
Samuel MampunzaUniversité Protestante du Congo, Kinshasa, Democratic Republic of the Congo. Electronic address: mampunza.samuel@upc.ac.cd.
Peyton ThompsonDivision of Infectious Diseases, Department of Pediatrics, University of North Carolina, Chapel Hill, NC 27599, USA. Electronic address: peyton_thompson@med.unc.edu.

Funding

Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/MalignanciesU54CA254568 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI ANASTOS, KATHRYN M. · 2020 to 2024
$5.1M
Characterizing Hepatitis B Transmission in Congolese ChildrenK08AI148607 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THOMPSON, PEYTON J · 2020 to 2024
$1.0M
NCI NIH HHS U54 CA254568NIAID NIH HHS K08 AI148607Wellcome Trust
6 · The paper itself

Abstract

The COVID-19 pandemic has disrupted access to, adherence to, and perceptions of routine vaccinations. We developed the Shift in Vaccine Confidence (SVC) survey tool to assess the impact of the pandemic on routine vaccinations, with a focus on the HBV vaccine, in Kinshasa, Democratic Republic of Congo (DRC). This study describes the content validation steps we conducted to ensure the survey tool is meaningful to measure changes in vaccine confidence to regular immunization (HBV vaccine) due to the pandemic. Three rounds of stakeholder feedback from a DRC-based study team, content and measurement experts, and study participants allowed us to produce a measure with improved readability and clarity.

Indexed as

COVID-19Hepatitis B VaccinesDemocratic Republic of the CongoHumansPandemicsPerceptionHepatitis B VaccinesCOVID-19 vaccinehepatitis B virus vaccineSurvey toolVaccine hesitancy

Identifiers

PMID36549941
PMCPMC9755009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.